Biofrontera Inc.
BFRI
$0.9252
-$0.0385-4.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.15% | -31.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.15% | -31.62% | |||
| Cost of Revenue | -19.16% | -38.01% | |||
| Gross Profit | 20.08% | -26.99% | |||
| SG&A Expenses | 22.37% | 5.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.42% | -7.96% | |||
| Operating Income | -11.70% | -165.60% | |||
| Income Before Tax | -26.14% | -200.50% | |||
| Income Tax Expenses | 2,200.00% | 66.67% | |||
| Earnings from Continuing Operations | -26.67% | -201.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.67% | -201.07% | |||
| EBIT | -11.70% | -165.60% | |||
| EBITDA | -11.84% | -169.25% | |||
| EPS Basic | -20.21% | -156.69% | |||
| Normalized Basic EPS | -19.76% | -21.01% | |||
| EPS Diluted | -20.21% | -28.17% | |||
| Normalized Diluted EPS | -19.76% | -21.01% | |||
| Average Basic Shares Outstanding | 5.38% | 17.28% | |||
| Average Diluted Shares Outstanding | 5.38% | 17.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||